Načítá se...
The P2 promoter of the IGF1 gene is a major epigenetic locus for GH responsiveness
Short children using growth hormone (GH) to accelerate their growth respond to this treatment with a variable efficacy. The causes of this individual variability are multifactorial and could involve epigenetics. Quantifying the impact of epigenetic variation on response to treatments is an emerging...
Uloženo v:
| Vydáno v: | Pharmacogenomics J |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Nature Publishing Group
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4746489/ https://ncbi.nlm.nih.gov/pubmed/25869012 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/tpj.2015.26 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|